NTAP
64
2
UPS
41
-4
NOV
58
3
ZBH
60
-2
FRT
39
-2
SYK
64
-4
HCP
58
4
K
53
2
PVH
52
-3
FMC
31
5
AFL
46
-3
PDCO
35
-3
EQIX
60
-2
SYF
85
2
GRMN
62
-3
CSCO
63
2
DLTR
34
-4
IP
70
2
AZO
46
-3
WAT
47
5
NTAP
64
2
UPS
41
-4
NOV
58
3
ZBH
60
-2
FRT
39
-2
SYK
64
-4
HCP
58
4
K
53
2
PVH
52
-3
FMC
31
5
AFL
46
-3
PDCO
35
-3
EQIX
60
-2
SYF
85
2
GRMN
62
-3
CSCO
63
2
DLTR
34
-4
IP
70
2
AZO
46
-3
WAT
47
5
Financhill
Back

Arcturus Therapeutics Holdings Vs. Fulcrum Therapeutics Industry Stock Comparison

Sell
28

ARCT
Arcturus Therapeutics Holdings

Last Price:
16.58
Seasonality Move:
13.46%
Sell
32

FULC
Fulcrum Therapeutics

Last Price:
3.07
Seasonality Move:
63.73%
Sell
28
Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings a Buy, Sell or Hold?

  • The current Arcturus Therapeutics Holdings [ARCT] share price is $16.17. The Score for ARCT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • ARCT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Fulcrum Therapeutics (FULC) is a Sell

Is Fulcrum Therapeutics a Buy, Sell or Hold?

  • The current Fulcrum Therapeutics [FULC] share price is $2.99. The Score for FULC is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • FULC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARCT Stock Price Chart

What is Arcturus Therapeutics Holdings's stock price today?

  • The Arcturus Therapeutics Holdings share price today is $16.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing selling pressure, which indicates risk of future bearish movement.

FULC Stock Price Chart

What is Fulcrum Therapeutics's stock price today?

  • The Fulcrum Therapeutics share price today is $2.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing slight selling pressure.

ARCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.92 Sell
Relative Strength Index (14 RSI): 37.34 Sell
Chaikin Money Flow: -345332 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.45 - 20.15) Sell
Bollinger Bands (100): (18.84 - 22.98) Sell

FULC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 32.8 Sell
Chaikin Money Flow: -260754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.12 - 3.52) Sell
Bollinger Bands (100): (3.37 - 8.57) Sell

ARCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.99 Sell
20-day SMA: 18.38 Sell
50-day SMA: 20.37 Sell
200-day SMA: 26.86 Sell
8-day EMA: 17.54 Sell
20-day EMA: 18.49 Sell
50-day EMA: 19.84 Sell
200-day EMA: 24.12 Sell

FULC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.28 Sell
20-day SMA: 3.29 Sell
50-day SMA: 3.52 Sell
200-day SMA: 7.22 Sell
8-day EMA: 3.17 Sell
20-day EMA: 3.33 Sell
50-day EMA: 4.09 Sell
200-day EMA: 6.03 Sell

Arcturus Therapeutics Holdings Earnings Growth & ARCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.71 per share.

Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.50 per share, and a decrease next year of $0.91 per share.

Arcturus Therapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Fulcrum Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):